All Stories

  1. Drug–drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer

    Article • Drug Design Development and Therapy, March 2017, Dove Medical Press

    Dr Gab-jin Park

  2. Retracted: Physiologically based pharmacokinetic predictions of intestinal BCRP-mediated effect of telmisartan on the pharmacokinetics of rosuvastatin in humans

    Article • Biopharmaceutics & Drug Disposition, February 2017, Wiley

    Dr Gab-jin Park

  3. Exposure–response model for sibutramine and placebo: suggestion for application to long-term weight-control drug development

    Article • Drug Design Development and Therapy, September 2015, Dove Medical Press

    Dr Gab-jin Park

  4. Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects

    Article • Drug Design Development and Therapy, February 2015, Taylor & Francis

    Dr Gab-jin Park